Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Miechow

5 clinical trials in Miechow, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Miechow at a glance
5
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

5 trials in Miechow

Open in trial search
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:OMECAMTIV MECARBIL
  • Sponsor:Cytokinetics Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Darbepoetin Alfa
  • Sponsor:Genexine Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Dyslipidaemia

Not recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Evolocumab
  • Sponsor:Amgen Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Obicetrapib
  • Sponsor:NewAmsterdam Pharma B.V.

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Miechow

What the registry says about research in the country

01 Cardiovascular Research

Innovative research focusing on atherosclerotic cardiovascular disease (ASCVD) treatments, evaluating new therapeutic approaches for patients with arterial plaque buildup. Current trials are examining advanced lipid-modifying therapies to reduce major cardiovascular events.

  • Arterial plaque management
  • Cardiovascular event prevention
  • Lipid modification strategies

Studies aim to improve outcomes for patients with established cardiovascular conditions through targeted interventions.

02 Nephrology Studies

Comprehensive research into chronic kidney disease (CKD) complications, with particular focus on anemia management in dialysis patients. Studies are comparing different treatment options to optimize hemoglobin level control.

  • Anemia management
  • Dialysis patient care
  • Hemoglobin regulation

Trials are designed to enhance the quality of life for patients undergoing regular dialysis treatment.

03 Inflammatory Disease Research

Advanced studies examining inflammatory markers in end-stage kidney disease (ESKD) patients, focusing on reducing C-reactive protein levels. Research explores the connection between inflammation and cardiovascular outcomes in dialysis patients.

  • Inflammatory biomarkers
  • ESKD management
  • Cardiovascular complications

Investigations aim to develop targeted therapies for reducing inflammation in vulnerable patient populations.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.